KyooBe Tech GmbH

Based on our extensive expertise in the field of biomanufacturing, KyooBe Tech GmbH focuses on the development and commercialization of innovative production technologies for biopharmaceuticals. We develop pioneering, automated platform technologies that significantly increase efficiency and flexibility in biopharmaceutical production. 

We combine state-of-the-art robotics, automation and biotechnological expertise to create sustainable and integrated process solutions. We understand our customer's complex production processes and address challenges with our interdisciplinary approach. Together, we are shaping the next generation of biopharmaceutical manufacturing. 

Our activities focus on the areas of pathogen inactivation and the automated production of personalized cell and gene therapies. We address current challenges in these areas with two product lines: 

INACTIVATE: an innovative technology for pathogen inactivation using low-energy electron irradiation, which offers solutions for high-throughput systems, e.g. in vaccine production. Our eFIT platforms are available on a laboratory and production scale and can be seamlessly integrated into existing process infrastructures. The technology also addresses applications in the field of pathogen reduction for biologics and blood products. 

MOSAIC: A modular platform that automates the production of cell therapies for personalized medicine, making it accessible to a wide range of patients. The system is divided into individual GMP-compliant units that can carry out all of the steps in the production of personalized cell therapies. Fully automated and modular, MOSAIC offers maximum scalability and flexibility to adapt to customer-specific production requirements. 

With a vision to revolutionize biopharmaceutical manufacturing through innovative automation and intelligent systems, KyooBe Tech is driving change in the industry and positioning itself as a trusted partner for forward-thinking companies.